Cargando…
Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income
OBJECTIVES: Testing and treatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are highly effective, high-impact interventions. This article aims to estimate the cost-effectiveness of scaling up these interventions by scenarios, regions, and income groups. METHODS: We modeled co...
Autores principales: | Tordrup, David, Hutin, Yvan, Stenberg, Karin, Lauer, Jeremy A., Hutton, David W., Toy, Mehlika, Scott, Nick, Chhatwal, Jagpreet, Ball, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806510/ https://www.ncbi.nlm.nih.gov/pubmed/33248510 http://dx.doi.org/10.1016/j.jval.2020.06.015 |
Ejemplares similares
-
Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in Vietnam
por: Due, Ong The, et al.
Publicado: (2020) -
Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan
por: Zhuo, Yueran, et al.
Publicado: (2020) -
Costs and health impact of delayed implementation of a national hepatitis B treatment program in China
por: Toy, Mehlika, et al.
Publicado: (2022) -
Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China
por: Toy, Mehlika, et al.
Publicado: (2015) -
Preventing hepatitis B virus infection: milestones and targets
por: Hutin, Yvan, et al.
Publicado: (2018)